Express Scripts praises, then takes credit for Gilead's authorized generics launches

With its hepatitis C franchise suffering from pricing pressure, Gilead Sciences has unveiled a plan to release authorized generics to its own medications at a fraction of the price. Due to drug market dynamics, the tactic could actually reach new patients and potentially grow sales.  

Now, Express Scripts is taking credit for the idea. In a post after Gilead’s announcement, the pharmacy benefit giant said it suggested such a move in its response to the Trump administration’s drug pricing blueprint, released in May.